Efficacy of preoperative therapy in patients with high and low risk of distant metastasis in non-small cell lung cancer

Background. To select the optimal treatment for non-small cell lung cancer (NSCLC), it is important to predict the risk of distant metastasis and the effectiveness of therapy. The effect of neoadjuvant chemotherapy (NAC) on distant metastasis remains poorly understood. In this study we evaluated the...

Full description

Bibliographic Details
Main Authors: O. V. Pankova, L. A. Tashireva, E. O. Rodionov, S. V. Мiller, T. S. Gerashchenko, D. S. Pismenny, M. E. Zavyalova, E. V. Denisov, V. M. Perelmuter
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Tomsk National Research Medical Center 2023-01-01
Series:Сибирский онкологический журнал
Subjects:
Online Access:https://www.siboncoj.ru/jour/article/view/2370
_version_ 1797875761945772032
author O. V. Pankova
L. A. Tashireva
E. O. Rodionov
S. V. Мiller
T. S. Gerashchenko
D. S. Pismenny
M. E. Zavyalova
E. V. Denisov
V. M. Perelmuter
author_facet O. V. Pankova
L. A. Tashireva
E. O. Rodionov
S. V. Мiller
T. S. Gerashchenko
D. S. Pismenny
M. E. Zavyalova
E. V. Denisov
V. M. Perelmuter
author_sort O. V. Pankova
collection DOAJ
description Background. To select the optimal treatment for non-small cell lung cancer (NSCLC), it is important to predict the risk of distant metastasis and the effectiveness of therapy. The effect of neoadjuvant chemotherapy (NAC) on distant metastasis remains poorly understood. In this study we evaluated the feasibility of predicting the risk of distant metastasis and effectiveness of various treatment options for pre- and intraoperative therapy in NSCLC patients with high and low risk of distant metastasis, divided based on the assessment of morphological changes in the epithelium of small bronchi located near the primary tumor.Material and Methods. The study included 171 patients with NSCLC (T1-4N0-3M0). Various premalignant lesions: isolated basal cell hyperplasia (BCH+SM-D-), basal cell hyperplasia with squamous cell metaplasia (BCH+SM+D-) and squamous cell metaplasia with dysplasia (BCH-SM+D+) were identified in the bronchial epithelium of small bronchi taken at a distance of 3–5 cm from the tumor. Preliminary studies have shown that the detection of BCH+SM-D- or BCH-SM+D-in small bronchi are the markers of high risk of NSCLC distant metastasis, and the detection of BCH+SM+D- and BCH-SM-D- are the markers of low risk of NSCLC distant metastasis. 52.6 % of patients (90/171) received 2–3 courses of neoadjuvant chemotherapy (NAC), 41.1 % (37/90) of patients underwent intraoperative radiation therapy (IORT) at a single dose of 10–15 Gy and 47.4 % (81/171) of patients received platinum-based adjuvant chemotherapy (AC).Results. Both treatment options (NAC+IORT+ and NAC+IORT–) effectively reduced the incidence of distant metastases in the high-risk group patients during the first 2 years of follow-up compared with the high-risk group patients who did not received therapy. In the low-risk group patients, distant metastases rarely occurred, regardless of the treatment option. Adjuvant chemotherapy was found to have no influence on the frequency of distant metastases. Metastasis-free and overall survival rates were better in the low-risk group patients or in patients who received the NAC+IORT+ regimen.Conclusion. Combination of NAC and IORT resulted in the increase in metastasis-free and overall survival rates.
first_indexed 2024-04-10T01:51:40Z
format Article
id doaj.art-f06aab916cf44c66917dc40cc909644e
institution Directory Open Access Journal
issn 1814-4861
2312-3168
language Russian
last_indexed 2024-04-10T01:51:40Z
publishDate 2023-01-01
publisher Russian Academy of Sciences, Tomsk National Research Medical Center
record_format Article
series Сибирский онкологический журнал
spelling doaj.art-f06aab916cf44c66917dc40cc909644e2023-03-13T09:05:56ZrusRussian Academy of Sciences, Tomsk National Research Medical CenterСибирский онкологический журнал1814-48612312-31682023-01-01216253710.21294/1814-4861-2022-21-6-25-371060Efficacy of preoperative therapy in patients with high and low risk of distant metastasis in non-small cell lung cancerO. V. Pankova0L. A. Tashireva1E. O. Rodionov2S. V. Мiller3T. S. Gerashchenko4D. S. Pismenny5M. E. Zavyalova6E. V. Denisov7V. M. Perelmuter8Научно-исследовательский институт онкологии, Томский национальный исследовательский медицинский центр Российской академии наукНаучно-исследовательский институт онкологии, Томский национальный исследовательский медицинский центр Российской академии наукНаучно-исследовательский институт онкологии, Томский национальный исследовательский медицинский центр Российской академии наукНаучно-исследовательский институт онкологии, Томский национальный исследовательский медицинский центр Российской академии наукНаучно-исследовательский институт онкологии, Томский национальный исследовательский медицинский центр Российской академии наукНаучно-исследовательский институт онкологии, Томский национальный исследовательский медицинский центр Российской академии наукНаучно-исследовательский институт онкологии, Томский национальный исследовательский медицинский центр Российской академии наукНаучно-исследовательский институт онкологии, Томский национальный исследовательский медицинский центр Российской академии наукНаучно-исследовательский институт онкологии, Томский национальный исследовательский медицинский центр Российской академии наукBackground. To select the optimal treatment for non-small cell lung cancer (NSCLC), it is important to predict the risk of distant metastasis and the effectiveness of therapy. The effect of neoadjuvant chemotherapy (NAC) on distant metastasis remains poorly understood. In this study we evaluated the feasibility of predicting the risk of distant metastasis and effectiveness of various treatment options for pre- and intraoperative therapy in NSCLC patients with high and low risk of distant metastasis, divided based on the assessment of morphological changes in the epithelium of small bronchi located near the primary tumor.Material and Methods. The study included 171 patients with NSCLC (T1-4N0-3M0). Various premalignant lesions: isolated basal cell hyperplasia (BCH+SM-D-), basal cell hyperplasia with squamous cell metaplasia (BCH+SM+D-) and squamous cell metaplasia with dysplasia (BCH-SM+D+) were identified in the bronchial epithelium of small bronchi taken at a distance of 3–5 cm from the tumor. Preliminary studies have shown that the detection of BCH+SM-D- or BCH-SM+D-in small bronchi are the markers of high risk of NSCLC distant metastasis, and the detection of BCH+SM+D- and BCH-SM-D- are the markers of low risk of NSCLC distant metastasis. 52.6 % of patients (90/171) received 2–3 courses of neoadjuvant chemotherapy (NAC), 41.1 % (37/90) of patients underwent intraoperative radiation therapy (IORT) at a single dose of 10–15 Gy and 47.4 % (81/171) of patients received platinum-based adjuvant chemotherapy (AC).Results. Both treatment options (NAC+IORT+ and NAC+IORT–) effectively reduced the incidence of distant metastases in the high-risk group patients during the first 2 years of follow-up compared with the high-risk group patients who did not received therapy. In the low-risk group patients, distant metastases rarely occurred, regardless of the treatment option. Adjuvant chemotherapy was found to have no influence on the frequency of distant metastases. Metastasis-free and overall survival rates were better in the low-risk group patients or in patients who received the NAC+IORT+ regimen.Conclusion. Combination of NAC and IORT resulted in the increase in metastasis-free and overall survival rates.https://www.siboncoj.ru/jour/article/view/2370нмрлметастазированиенахтиолтбазальноклеточная гиперплазиядисплазия.
spellingShingle O. V. Pankova
L. A. Tashireva
E. O. Rodionov
S. V. Мiller
T. S. Gerashchenko
D. S. Pismenny
M. E. Zavyalova
E. V. Denisov
V. M. Perelmuter
Efficacy of preoperative therapy in patients with high and low risk of distant metastasis in non-small cell lung cancer
Сибирский онкологический журнал
нмрл
метастазирование
нахт
иолт
базальноклеточная гиперплазия
дисплазия.
title Efficacy of preoperative therapy in patients with high and low risk of distant metastasis in non-small cell lung cancer
title_full Efficacy of preoperative therapy in patients with high and low risk of distant metastasis in non-small cell lung cancer
title_fullStr Efficacy of preoperative therapy in patients with high and low risk of distant metastasis in non-small cell lung cancer
title_full_unstemmed Efficacy of preoperative therapy in patients with high and low risk of distant metastasis in non-small cell lung cancer
title_short Efficacy of preoperative therapy in patients with high and low risk of distant metastasis in non-small cell lung cancer
title_sort efficacy of preoperative therapy in patients with high and low risk of distant metastasis in non small cell lung cancer
topic нмрл
метастазирование
нахт
иолт
базальноклеточная гиперплазия
дисплазия.
url https://www.siboncoj.ru/jour/article/view/2370
work_keys_str_mv AT ovpankova efficacyofpreoperativetherapyinpatientswithhighandlowriskofdistantmetastasisinnonsmallcelllungcancer
AT latashireva efficacyofpreoperativetherapyinpatientswithhighandlowriskofdistantmetastasisinnonsmallcelllungcancer
AT eorodionov efficacyofpreoperativetherapyinpatientswithhighandlowriskofdistantmetastasisinnonsmallcelllungcancer
AT svmiller efficacyofpreoperativetherapyinpatientswithhighandlowriskofdistantmetastasisinnonsmallcelllungcancer
AT tsgerashchenko efficacyofpreoperativetherapyinpatientswithhighandlowriskofdistantmetastasisinnonsmallcelllungcancer
AT dspismenny efficacyofpreoperativetherapyinpatientswithhighandlowriskofdistantmetastasisinnonsmallcelllungcancer
AT mezavyalova efficacyofpreoperativetherapyinpatientswithhighandlowriskofdistantmetastasisinnonsmallcelllungcancer
AT evdenisov efficacyofpreoperativetherapyinpatientswithhighandlowriskofdistantmetastasisinnonsmallcelllungcancer
AT vmperelmuter efficacyofpreoperativetherapyinpatientswithhighandlowriskofdistantmetastasisinnonsmallcelllungcancer